← Leaderboards
Pamela M Martin
Augusta University
$5,546,091
Attributed
$7,020,317
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,020,317 · 8
By mechanism
R01$2,209,765 · 1
R44$1,911,440 · 1
T32$1,268,528 · 2
R00$729,748 · 1
R21$420,937 · 1
R41$299,899 · 1
Top collaborators
- Edward Gomperts3 shared
- Ravirajsinh Jadeja3 shared
Most similar at Augusta University
Same institution · by research overlap
- Martha S Tingen$3,730,239
- Neal L Weintraub$17,807,491
- Nagendra Singh$3,980,885
- Muthusamy Thangaraju$2,561,820
- Ban A Majeed$437,331
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessRetinaAnimal ModelDiabetes MellitusMolecularPathologicMouse ModelDiabetic RetinopathyAdultEventIn VitroMaintenanceCellsCell TypeLaboratoriesRetinal DegenerationClinically RelevantMonitorDiabeticRetinalOxidative StressPublishingInflammationKnockout Mice
Grant awards (21)
HBI-002 to Treat Diabetic Retinopathy$961,240
R44 · FY2025 · EY
The Meharry Research Training Initiative$437,552
T32 · FY2025 · GM · contact PI
Research Training in Cardiovascular Biology at Meharry$176,497
T32 · FY2025 · HL · contact PI
HBI-002 to Treat Diabetic Retinopathy$950,200
R44 · FY2024 · EY
G-RISE at Meharry Medical College$450,679
T32 · FY2024 · GM · contact PI
Research Training in Cardiovascular Biology at Meharry$203,800
T32 · FY2024 · HL · contact PI
HBI-002 to Treat Diabetic Retinopathy$299,899
R41 · FY2021 · EY
Understanding the relevance of hemoglobin in RPE$192,187
R21 · FY2020 · EY · contact PI
Understanding the relevance of hemoglobin in RPE$228,750
R21 · FY2019 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$407,500
R01 · FY2018 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$471,047
R01 · FY2017 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$20,875
R01 · FY2017 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$471,047
R01 · FY2016 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$367,500
R01 · FY2015 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$96,796
R01 · FY2015 · EY · contact PI
Molecular basis of inflammation in retina, and novel strategies for limiting it$375,000
R01 · FY2014 · EY · contact PI
SMCT1 & SMCT2: expression in retina & relevance to diabetic retinopathy$235,032
R00 · FY2011 · EY · contact PI
SMCT1 & SMCT2: expression in retina & relevance to diabetic retinopathy$245,716
R00 · FY2010 · EY · contact PI
SMCT1 & SMCT2: expression in retina & relevance to diabetic retinopathy$249,000
R00 · FY2009 · EY · contact PI
SMCT1 & SMCT2: expression in retina & relevance to diabetic retinopathy$90,000
K99 · FY2008 · EY · contact PI
SMCT1 & SMCT2: expression in retina & relevance to diabetic retinopathy$90,000
K99 · FY2007 · EY · contact PI